Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biopharmaceuticals
Pall Corporation Acquires Molecular Diagnostics Manufacturer GeneSystems
September 20th, 2008
Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, announced the purchase of GeneSystems, a privately held French biotechnology company that has developed a unique, easy-to-use and cost-effective molecular diagnostics platform. The acquisition of GeneSystems, with its patented approach to rapid microbiological detection equipment and disposables, expands Pall's Total Fluid ManagementSM (TFM) capabilities in the $1 billion biopharmaceuticals process monitoring market. The acquisition also presents Pall with new opportunities in its environmental, food and beverage and water markets. Process monitoring includes...
Source: Law & Health Weekly (2008-09-20)
|
